相关实验视频
Updated: Jul 7, 2026

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
在老年人中不对称的二甲基氨基,血压和 perfusion
Jan T Kielstein1, Stefanie M Bode-Böger, Jürgen C Frölich
1Department of Internal Medicine, Medical School Hannover, Germany.
Circulation
|April 16, 2003
概括
不对称二甲基氨酸 (ADMA) 的升高水平,一种氧化 (NO) 抑制剂,与老年人的脏血流减少和血压升高有关. 这表明ADMA在与年龄相关的高血压中起作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管科学 心血管科学
- 老年学是指老年学的学科.
背景情况:
- 减少氧化 (NO) 的可用性与与年龄相关的动脉和血压的增加有关.
- 非对称二甲基氨基 (ADMA) 是NO合成酶的内源抑制剂.
- 这项研究比较了年轻人,健康的老年人和高血压的老年人的动力学和ADMA水平.
研究的目的:
- 调查不对称二甲基氨基 (ADMA) 在动力学和血压中与年龄相关的变化中的作用.
- 为了比较ADMA水平和年轻健康成年人,老年健康成年人和患有基本高血压的老年人之间的功能.
主要方法:
- 测量了不对称二甲基氨酸 (ADMA) 的血液度.
- 评估了脏血液动力学,包括血管阻力 (RVR) 和有效脏血流 (ERPF).
- 在三个组之间进行了比较:年轻的健康受试者,老年健康受试者和患有基本高血压的老年受试者.
主要成果:
- 与年轻人相比,老年人表现出明显更高的血ADMA度和血管抵抗 (RVR),有效脏血流量 (ERPF) 较低.
- 高血压的老年人表现出比年轻人和老年健康人群更高的ADMA水平和RVR,以及较低的ERPF.
- 后勤回归分析确定ADMA是ERPF和RVR的独立决定因素,以及血清葡萄糖,血压的预测指标.
结论:
- 在老年人中,ADMA的积累与 perfusion 降低和血压升高有关.
- 这些发现支持了ADMA导致与年龄相关的功能下降和高血压的假设.
- 向ADMA可能为管理与年龄相关的血管功能障碍和高血压提供治疗策略.
相关概念视频
Alterations in Blood Pressure
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Studies I: ABG and VBG
Blood studies are critical in the medical field, enabling healthcare professionals to assess a patient's health status accurately. This page will focus on two significant blood studies: Arterial Blood Gas (ABG) and Venous Blood Gas (VBG).
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

